The Cyclooxygenase 2 Inhibitor Etoricoxib as Adjunctive Therapy in Tuberculosis Impairs Macrophage Control of Mycobacterial Growth
Article in The Journal of Infectious Diseases (September 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in The Journal of Infectious Diseases (September 2023)
Article in Tuberculosis (August 2022)
Article in Pathogens (December 2021)